Prognosis of Resected Ampullary Adenocarcinoma by Preoperative Serum CA19-9 Levels and Platelet-Lymphocyte Ratio View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2008-06-10

AUTHORS

Richard A. Smith, Paula Ghaneh, Robert Sutton, Michael Raraty, Fiona Campbell, John P. Neoptolemos

ABSTRACT

BackgroundThe objective of this study was to evaluate whether preoperative CA19-9 levels and the platelet–lymphocyte ratio (PLR) might reflect prognostic indices for resected ampullary adenocarcinoma.Materials and MethodsData were collected prospectively over a 10-year period for consecutive patients undergoing pancreatoduodenectomy for malignancy.ResultsBoth preoperative PLR and CA19-9 results were available in 52 cases of resected ampullary adenocarcinoma. Preoperative CA19-9 levels of ≤150 kU/l (or ≤300 kU/l in the presence of bilirubin levels >35 µmol/l) and a PLR of ≤160 were found to represent the optimal cut-off values to risk stratify patients. If both levels were elevated (n = 8), patients had a median overall survival of 10.1 months. If either CA19-9 or PLR were elevated individually (n = 23), patients had a median survival of 25.2 months. For cases where both levels were less than the cut-off values (n = 21), the median overall survival time was not reached but was greater than 60 months (log rank, p < 0.001). This preoperative risk stratification was found to remain a significant independent predictor of survival on multivariate analysis (Cox, p = 0.001) alongside resection margin status (p = 0.002) and tumor size (p = 0.051).ConclusionsPreoperative CA19-9 and PLR both merit further evaluation as prognostic indices in resected ampullary adenocarcinoma. More... »

PAGES

1422-1428

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11605-008-0554-3

DOI

http://dx.doi.org/10.1007/s11605-008-0554-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1022255030

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18543046


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adenocarcinoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Platelets", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "CA-19-9 Antigen", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphocyte Count", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphocytes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pancreatic Ducts", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pancreatic Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pancreaticoduodenectomy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Platelet Count", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Surgery and Oncology, School of Cancer Studies, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St., L69 3GA, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.415970.e", 
          "name": [
            "Division of Surgery and Oncology, School of Cancer Studies, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St., L69 3GA, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Smith", 
        "givenName": "Richard A.", 
        "id": "sg:person.014067200621.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014067200621.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Surgery and Oncology, School of Cancer Studies, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St., L69 3GA, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.415970.e", 
          "name": [
            "Division of Surgery and Oncology, School of Cancer Studies, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St., L69 3GA, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ghaneh", 
        "givenName": "Paula", 
        "id": "sg:person.07372440237.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07372440237.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Surgery and Oncology, School of Cancer Studies, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St., L69 3GA, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.415970.e", 
          "name": [
            "Division of Surgery and Oncology, School of Cancer Studies, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St., L69 3GA, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sutton", 
        "givenName": "Robert", 
        "id": "sg:person.0673243233.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673243233.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Surgery and Oncology, School of Cancer Studies, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St., L69 3GA, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.415970.e", 
          "name": [
            "Division of Surgery and Oncology, School of Cancer Studies, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St., L69 3GA, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Raraty", 
        "givenName": "Michael", 
        "id": "sg:person.014701673553.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014701673553.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, L69 3GA, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.415970.e", 
          "name": [
            "Department of Pathology, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, L69 3GA, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Campbell", 
        "givenName": "Fiona", 
        "id": "sg:person.0646035141.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646035141.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Surgery and Oncology, School of Cancer Studies, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St., L69 3GA, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.415970.e", 
          "name": [
            "Division of Surgery and Oncology, School of Cancer Studies, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St., L69 3GA, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Neoptolemos", 
        "givenName": "John P.", 
        "id": "sg:person.0750565077.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750565077.18"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf01542654", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027172486", 
          "https://doi.org/10.1007/bf01542654"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6602305", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043982539", 
          "https://doi.org/10.1038/sj.bjc.6602305"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02573067", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035777874", 
          "https://doi.org/10.1007/bf02573067"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1994.93", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037762550", 
          "https://doi.org/10.1038/bjc.1994.93"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02305535", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048784717", 
          "https://doi.org/10.1007/bf02305535"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2008-06-10", 
    "datePublishedReg": "2008-06-10", 
    "description": "BackgroundThe objective of this study was to evaluate whether preoperative CA19-9 levels and the platelet\u2013lymphocyte ratio (PLR) might reflect prognostic indices for resected ampullary adenocarcinoma.Materials and MethodsData were collected prospectively over a 10-year period for consecutive patients undergoing pancreatoduodenectomy for malignancy.ResultsBoth preoperative PLR and CA19-9 results were available in 52 cases of resected ampullary adenocarcinoma. Preoperative CA19-9 levels of \u2264150\u00a0kU/l (or \u2264300\u00a0kU/l in the presence of bilirubin levels >35\u00a0\u00b5mol/l) and a PLR of \u2264160 were found to represent the optimal cut-off values to risk stratify patients. If both levels were elevated (n = 8), patients had a median overall survival of 10.1\u00a0months. If either CA19-9 or PLR were elevated individually (n = 23), patients had a median survival of 25.2\u00a0months. For cases where both levels were less than the cut-off values (n = 21), the median overall survival time was not reached but was greater than 60\u00a0months (log rank, p < 0.001). This preoperative risk stratification was found to remain a significant independent predictor of survival on multivariate analysis (Cox, p = 0.001) alongside resection margin status (p = 0.002) and tumor size (p = 0.051).ConclusionsPreoperative CA19-9 and PLR both merit further evaluation as prognostic indices in resected ampullary adenocarcinoma.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s11605-008-0554-3", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1116755", 
        "issn": [
          "1091-255X", 
          "1873-4626"
        ], 
        "name": "Journal of Gastrointestinal Surgery", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "12"
      }
    ], 
    "keywords": [
      "platelet-lymphocyte ratio", 
      "CA19-9 levels", 
      "preoperative CA19-9 levels", 
      "ampullary adenocarcinoma", 
      "prognostic index", 
      "CA19-9", 
      "preoperative serum CA19-9 level", 
      "preoperative platelet-lymphocyte ratio", 
      "median overall survival time", 
      "serum CA19-9 levels", 
      "median overall survival", 
      "preoperative risk stratification", 
      "resection margin status", 
      "overall survival time", 
      "significant independent predictors", 
      "merit further evaluation", 
      "median survival", 
      "consecutive patients", 
      "overall survival", 
      "margin status", 
      "risk stratification", 
      "independent predictors", 
      "tumor size", 
      "BackgroundThe objective", 
      "survival time", 
      "adenocarcinoma", 
      "patients", 
      "multivariate analysis", 
      "kU/", 
      "further evaluation", 
      "months", 
      "survival", 
      "pancreatoduodenectomy", 
      "levels", 
      "prognosis", 
      "malignancy", 
      "MethodsData", 
      "index", 
      "risk", 
      "predictors", 
      "cases", 
      "status", 
      "stratification", 
      "period", 
      "evaluation", 
      "study", 
      "ratio", 
      "objective", 
      "values", 
      "time", 
      "analysis", 
      "results", 
      "size", 
      "materials"
    ], 
    "name": "Prognosis of Resected Ampullary Adenocarcinoma by Preoperative Serum CA19-9 Levels and Platelet-Lymphocyte Ratio", 
    "pagination": "1422-1428", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1022255030"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11605-008-0554-3"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18543046"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11605-008-0554-3", 
      "https://app.dimensions.ai/details/publication/pub.1022255030"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-11-24T20:52", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_461.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s11605-008-0554-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11605-008-0554-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11605-008-0554-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11605-008-0554-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11605-008-0554-3'


 

This table displays all metadata directly associated to this object as RDF triples.

244 TRIPLES      21 PREDICATES      102 URIs      89 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11605-008-0554-3 schema:about N17685993b3184c6aaa679d3e1614ab37
2 N17ebc2112d964b0cacdcc7ec1621c8c4
3 N18ec8324cab1471ca90d4321a4153904
4 N1e00a151430f4fe49d6af42c818ef38e
5 N244b69ad1f18452fbc8e54d50b58ceeb
6 N24fc3425b3e94a2d866ea49c61af984e
7 N2f9877d4c1164ef8af55300bfee04603
8 N3bf352195e9c4026991042cf1d788a4e
9 N63f8f0d3a76643a39dd814e43e563493
10 N65737b0c5c51499bbb1f41e40d17cbe3
11 N87d5c331439c4e4986dfd2bf45f68edd
12 N8bb8528e2aeb41ba8dacc0e11156ee01
13 N91eb1c7e7c154590be7f8e67397454f6
14 N994ca06d4263456dbf8c3b0406593e2d
15 Nb0a9c2f03fb849d6b0ebcac0dfde4b23
16 Nb806ae0ca9944b089cb2abf65de5a7be
17 Ndea26693bc234fadab2afe3eee86770b
18 Nfa9ae0a9b8aa48ceaaecf6d03ab5fbad
19 anzsrc-for:11
20 anzsrc-for:1112
21 schema:author Nf4aee9d03d4d40abb21a2d9b3b6df68a
22 schema:citation sg:pub.10.1007/bf01542654
23 sg:pub.10.1007/bf02305535
24 sg:pub.10.1007/bf02573067
25 sg:pub.10.1038/bjc.1994.93
26 sg:pub.10.1038/sj.bjc.6602305
27 schema:datePublished 2008-06-10
28 schema:datePublishedReg 2008-06-10
29 schema:description BackgroundThe objective of this study was to evaluate whether preoperative CA19-9 levels and the platelet–lymphocyte ratio (PLR) might reflect prognostic indices for resected ampullary adenocarcinoma.Materials and MethodsData were collected prospectively over a 10-year period for consecutive patients undergoing pancreatoduodenectomy for malignancy.ResultsBoth preoperative PLR and CA19-9 results were available in 52 cases of resected ampullary adenocarcinoma. Preoperative CA19-9 levels of ≤150 kU/l (or ≤300 kU/l in the presence of bilirubin levels >35 µmol/l) and a PLR of ≤160 were found to represent the optimal cut-off values to risk stratify patients. If both levels were elevated (n = 8), patients had a median overall survival of 10.1 months. If either CA19-9 or PLR were elevated individually (n = 23), patients had a median survival of 25.2 months. For cases where both levels were less than the cut-off values (n = 21), the median overall survival time was not reached but was greater than 60 months (log rank, p < 0.001). This preoperative risk stratification was found to remain a significant independent predictor of survival on multivariate analysis (Cox, p = 0.001) alongside resection margin status (p = 0.002) and tumor size (p = 0.051).ConclusionsPreoperative CA19-9 and PLR both merit further evaluation as prognostic indices in resected ampullary adenocarcinoma.
30 schema:genre article
31 schema:isAccessibleForFree false
32 schema:isPartOf N1ed12d188ce44031bd6600824adb91b1
33 Nc5499084368e4262a1d212053a86e12d
34 sg:journal.1116755
35 schema:keywords BackgroundThe objective
36 CA19-9
37 CA19-9 levels
38 MethodsData
39 adenocarcinoma
40 ampullary adenocarcinoma
41 analysis
42 cases
43 consecutive patients
44 evaluation
45 further evaluation
46 independent predictors
47 index
48 kU/
49 levels
50 malignancy
51 margin status
52 materials
53 median overall survival
54 median overall survival time
55 median survival
56 merit further evaluation
57 months
58 multivariate analysis
59 objective
60 overall survival
61 overall survival time
62 pancreatoduodenectomy
63 patients
64 period
65 platelet-lymphocyte ratio
66 predictors
67 preoperative CA19-9 levels
68 preoperative platelet-lymphocyte ratio
69 preoperative risk stratification
70 preoperative serum CA19-9 level
71 prognosis
72 prognostic index
73 ratio
74 resection margin status
75 results
76 risk
77 risk stratification
78 serum CA19-9 levels
79 significant independent predictors
80 size
81 status
82 stratification
83 study
84 survival
85 survival time
86 time
87 tumor size
88 values
89 schema:name Prognosis of Resected Ampullary Adenocarcinoma by Preoperative Serum CA19-9 Levels and Platelet-Lymphocyte Ratio
90 schema:pagination 1422-1428
91 schema:productId N2f05a9fc212945e8b983c3b4c79d6e11
92 N430716a043f84778a615d1fdf83a5de1
93 N71f87eb9b6fe4d728bb28c9e4a4a942d
94 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022255030
95 https://doi.org/10.1007/s11605-008-0554-3
96 schema:sdDatePublished 2022-11-24T20:52
97 schema:sdLicense https://scigraph.springernature.com/explorer/license/
98 schema:sdPublisher N661beb71b54440a0bed2f4d33324c773
99 schema:url https://doi.org/10.1007/s11605-008-0554-3
100 sgo:license sg:explorer/license/
101 sgo:sdDataset articles
102 rdf:type schema:ScholarlyArticle
103 N17685993b3184c6aaa679d3e1614ab37 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Middle Aged
105 rdf:type schema:DefinedTerm
106 N17ebc2112d964b0cacdcc7ec1621c8c4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Blood Platelets
108 rdf:type schema:DefinedTerm
109 N18ec8324cab1471ca90d4321a4153904 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Lymphocyte Count
111 rdf:type schema:DefinedTerm
112 N1e00a151430f4fe49d6af42c818ef38e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Pancreatic Neoplasms
114 rdf:type schema:DefinedTerm
115 N1ed12d188ce44031bd6600824adb91b1 schema:issueNumber 8
116 rdf:type schema:PublicationIssue
117 N244b69ad1f18452fbc8e54d50b58ceeb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Aged
119 rdf:type schema:DefinedTerm
120 N24fc3425b3e94a2d866ea49c61af984e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Lymphocytes
122 rdf:type schema:DefinedTerm
123 N2f05a9fc212945e8b983c3b4c79d6e11 schema:name doi
124 schema:value 10.1007/s11605-008-0554-3
125 rdf:type schema:PropertyValue
126 N2f9877d4c1164ef8af55300bfee04603 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Follow-Up Studies
128 rdf:type schema:DefinedTerm
129 N3bf352195e9c4026991042cf1d788a4e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Prognosis
131 rdf:type schema:DefinedTerm
132 N430716a043f84778a615d1fdf83a5de1 schema:name dimensions_id
133 schema:value pub.1022255030
134 rdf:type schema:PropertyValue
135 N5bbd4d043a1046af8a03c04daa4418bb rdf:first sg:person.0750565077.18
136 rdf:rest rdf:nil
137 N63f8f0d3a76643a39dd814e43e563493 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Female
139 rdf:type schema:DefinedTerm
140 N65737b0c5c51499bbb1f41e40d17cbe3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Humans
142 rdf:type schema:DefinedTerm
143 N661beb71b54440a0bed2f4d33324c773 schema:name Springer Nature - SN SciGraph project
144 rdf:type schema:Organization
145 N67dcc15d480843d88e4cf41fc77b22cd rdf:first sg:person.0646035141.16
146 rdf:rest N5bbd4d043a1046af8a03c04daa4418bb
147 N6b94e4788b6341e8a44ba2f6a6cf7ddb rdf:first sg:person.014701673553.45
148 rdf:rest N67dcc15d480843d88e4cf41fc77b22cd
149 N71f87eb9b6fe4d728bb28c9e4a4a942d schema:name pubmed_id
150 schema:value 18543046
151 rdf:type schema:PropertyValue
152 N87d5c331439c4e4986dfd2bf45f68edd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Biomarkers, Tumor
154 rdf:type schema:DefinedTerm
155 N8bb8528e2aeb41ba8dacc0e11156ee01 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Platelet Count
157 rdf:type schema:DefinedTerm
158 N91eb1c7e7c154590be7f8e67397454f6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Male
160 rdf:type schema:DefinedTerm
161 N994ca06d4263456dbf8c3b0406593e2d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Adenocarcinoma
163 rdf:type schema:DefinedTerm
164 N9b7554cbc9484d4685af30d133eaabe2 rdf:first sg:person.0673243233.66
165 rdf:rest N6b94e4788b6341e8a44ba2f6a6cf7ddb
166 Nb0a9c2f03fb849d6b0ebcac0dfde4b23 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Pancreaticoduodenectomy
168 rdf:type schema:DefinedTerm
169 Nb806ae0ca9944b089cb2abf65de5a7be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Prospective Studies
171 rdf:type schema:DefinedTerm
172 Nc4a28cbbd93c4209baa56afad1b53192 rdf:first sg:person.07372440237.86
173 rdf:rest N9b7554cbc9484d4685af30d133eaabe2
174 Nc5499084368e4262a1d212053a86e12d schema:volumeNumber 12
175 rdf:type schema:PublicationVolume
176 Ndea26693bc234fadab2afe3eee86770b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Pancreatic Ducts
178 rdf:type schema:DefinedTerm
179 Nf4aee9d03d4d40abb21a2d9b3b6df68a rdf:first sg:person.014067200621.05
180 rdf:rest Nc4a28cbbd93c4209baa56afad1b53192
181 Nfa9ae0a9b8aa48ceaaecf6d03ab5fbad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name CA-19-9 Antigen
183 rdf:type schema:DefinedTerm
184 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
185 schema:name Medical and Health Sciences
186 rdf:type schema:DefinedTerm
187 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
188 schema:name Oncology and Carcinogenesis
189 rdf:type schema:DefinedTerm
190 sg:journal.1116755 schema:issn 1091-255X
191 1873-4626
192 schema:name Journal of Gastrointestinal Surgery
193 schema:publisher Springer Nature
194 rdf:type schema:Periodical
195 sg:person.014067200621.05 schema:affiliation grid-institutes:grid.415970.e
196 schema:familyName Smith
197 schema:givenName Richard A.
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014067200621.05
199 rdf:type schema:Person
200 sg:person.014701673553.45 schema:affiliation grid-institutes:grid.415970.e
201 schema:familyName Raraty
202 schema:givenName Michael
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014701673553.45
204 rdf:type schema:Person
205 sg:person.0646035141.16 schema:affiliation grid-institutes:grid.415970.e
206 schema:familyName Campbell
207 schema:givenName Fiona
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646035141.16
209 rdf:type schema:Person
210 sg:person.0673243233.66 schema:affiliation grid-institutes:grid.415970.e
211 schema:familyName Sutton
212 schema:givenName Robert
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673243233.66
214 rdf:type schema:Person
215 sg:person.07372440237.86 schema:affiliation grid-institutes:grid.415970.e
216 schema:familyName Ghaneh
217 schema:givenName Paula
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07372440237.86
219 rdf:type schema:Person
220 sg:person.0750565077.18 schema:affiliation grid-institutes:grid.415970.e
221 schema:familyName Neoptolemos
222 schema:givenName John P.
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750565077.18
224 rdf:type schema:Person
225 sg:pub.10.1007/bf01542654 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027172486
226 https://doi.org/10.1007/bf01542654
227 rdf:type schema:CreativeWork
228 sg:pub.10.1007/bf02305535 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048784717
229 https://doi.org/10.1007/bf02305535
230 rdf:type schema:CreativeWork
231 sg:pub.10.1007/bf02573067 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035777874
232 https://doi.org/10.1007/bf02573067
233 rdf:type schema:CreativeWork
234 sg:pub.10.1038/bjc.1994.93 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037762550
235 https://doi.org/10.1038/bjc.1994.93
236 rdf:type schema:CreativeWork
237 sg:pub.10.1038/sj.bjc.6602305 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043982539
238 https://doi.org/10.1038/sj.bjc.6602305
239 rdf:type schema:CreativeWork
240 grid-institutes:grid.415970.e schema:alternateName Department of Pathology, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, L69 3GA, Liverpool, UK
241 Division of Surgery and Oncology, School of Cancer Studies, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St., L69 3GA, Liverpool, UK
242 schema:name Department of Pathology, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, L69 3GA, Liverpool, UK
243 Division of Surgery and Oncology, School of Cancer Studies, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St., L69 3GA, Liverpool, UK
244 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...